SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharmaceuticals informs about proceedings of AGM

25 Sep 2021 Evaluate

Pharmaids Pharmaceuticals has informed that the 32nd AGM of the Company was held on 25th September’ 2021 through Video Conferencing (‘VC’)/ Other Audio-Visual Means (‘OAVM’) at 12:00 pm IST. In this regard, Pharmaids Pharmaceuticals has informed that the summary of the proceedings of the AGM of the Company. The Voting Results of the 32nd Annual General Meeting of the Company along with the Scrutinizer’s Report will be shared shortly and shall be placed on the Company’s website. The 32nd Annual General Meeting of the Company was concluded at 12:25 pm IST.

The above information is a part of company’s filings submitted to BSE.


Pharmaids Pharma Share Price

30.75 -0.17 (-0.55%)
21-Apr-2026 12:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1220.50
Cipla 1232.75
Zydus Lifesciences 927.80
Lupin 2321.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×